Biotricity Increases Patient Access to Cardiovascular Care with Launch of Biocare Cardiac

Biotricity Increases Patient Access to Cardiovascular Care with Launch of Biocare Cardiac

 Medical diagnostic and consumer healthcare technology provider, Biotricity, Inc., Nasdaq (BTCY) has launched a first-of-its-kind cardiac disease management solution that allows patients to be monitored remotely.

The program combines diagnostics, disease and lifestyle management and telemedicine and enables patients to engage with their treatment plan. The Biocare Cardiac program provides peace of mind and improves patients’ quality of life by reducing travel time to specialist appointments.

 Highlights

• Biotricity’s program provides actionable data for physicians to assist them in making treatment decisions quickly.
• Biotricity’s successful pilot programs were conducted at a medical facility with more than 40,000 heart patients in Oklahoma City, and at a medical practice caring for 20,000 cardiovascular patients in Kentucky.
• Biotricity’s remote monitoring tools are currently in use by more than 2,000 cardiologists nationwide.

Last month, Biotricity announced it had surpassed two billion recorded and analyzed heartbeats for atrial fibrillation using its Bioflux® high-precision, single-unit mobile cardiac telemetry device.